Immunomedics, Inc.
Immunomedics, Inc. (IMMU) Accused of Data Integrity Breach According to the complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between August 23, 2018
Immunomedics, Inc. (IMMU) Accused of Data Integrity Breach According to the complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between August 23, 2018
OneMain Holdings, Inc. (OMF) Officers and Directors Mislead Shareholders According to Class Action OneMain was created as a result of the acquisition of OneMain Financial Holdings, LLC by Springleaf Holdings,
Nvidia Corporation (NVDA) Accused of Touting its Revenue Guidance According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act of 1934 between
JA Solar Holdings Co., Ltd. (Formerly JASO) Accused of Depressing Stock Value Before Going Private According to the complaint against the company’s officers and directors for alleged violations of the Securities
Nobilis Health Corp. (HLTH) Accused of Overstating Revenue According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act of 1934 between May
XPO Logistics, Inc. (XPO) Accused of Dubious Tax Accounting To Cover Financial Strain According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act
Akorn, Inc. (AKRX) FDA Violations Results in Termination of Acquisition And Remediation Costs of $900 Million According to the complaint against the company’s officers and directors for breaches of fiduciary
Alnylam Pharmaceuticals, Inc. (ALNY) Overstated the Efficacy of its Onpattro Lipid Complex Injection According to the complaint against Alnylam’s officers and directors for alleged violations of the Securities Exchange Act
Dycom Industries, Inc. (DY) Accused of Failing to Disclose Permitting Uncertainties According to the complaint against Dycom’s officers and directors for alleged violations of the Securities Exchange Act of 1934
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.